{"schema_version":"secwatch.filing_event.v1","accession":"0001376339-22-000112","form_type":"8-K","ticker":"MDXG","cik":"0001376339","company_name":"MIMEDX GROUP, INC.","filed_at":"2022-09-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.553486+00:00","generated_at":"2026-06-23T15:07:32.798083+00:00","sec_items":["5.02","7.01","8.01","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"MiMedx appoints Todd Newton interim CEO; 2022 revenue growth outlook at low end of prior range","bullets":["Timothy R. Wright terminated as CEO effective immediately; K. Todd Newton appointed interim CEO.","Board formed Search Committee to find permanent CEO; includes Behrens, Bierman, Hawkins.","Board reduced to eight members; Newton no longer independent; Laurencin appointed to Audit Committee.","2022 full-year AWC product net sales expected at low end of 11-14% growth range (2021: $240M).","Q3 2022 AWC product net sales expected mid-single-digit growth vs Q3 2021 ($62.3M); total net sales expected to grow."],"urls":{"canonical":"https://secwatch.observer/filing/0001376339-22-000112","json":"https://secwatch.observer/filing/0001376339-22-000112.json","markdown":"https://secwatch.observer/filing/0001376339-22-000112.md","text":"https://secwatch.observer/filing/0001376339-22-000112.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1376339/000137633922000112/0001376339-22-000112-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1376339/000137633922000112/mdxg-20220903.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T15:07:32.798083+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"38e2c00cc2","claim":"Timothy R. Wright was terminated as Chief Executive Officer at MIMEDX GROUP, INC..","evidence_excerpt":"Mr. Wright also ceased to be a member of the board of directors effective upon the termination of his employment as Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633922000112/0001376339-22-000112-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"94856f3b9b","claim":"K. Todd Newton was appointed as Interim Chief Executive Officer at MIMEDX GROUP, INC..","evidence_excerpt":"appointed K. Todd Newton, a current director of the Company, as the Company’s interim Chief Executive Officer to replace Timothy R. Wright effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633922000112/0001376339-22-000112-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}